Inicio>>Signaling Pathways>> Tyrosine Kinase>> VEGFR>>Aflibercept

Aflibercept (Synonyms: VEGF Trap; VEGF-TRAPR1R2; VEGF-trapR1)

Catalog No.GC68628

Aflibercept (VEGF Trap) es un señuelo soluble de VEGFR que se compone de los dominios Ig de VEGFR1 y VEGFR2 fusionados con el dominio Fc de la IgG1 humana. Aflibercept inhibe la señalización del VEGF al bloquear las vías reguladas por el VEGF. Aflibercept puede ser utilizado en investigaciones sobre degeneración macular relacionada con la edad (AMD) y enfermedades cardiovasculares.

Products are for research use only. Not for human use. We do not sell to patients.

Aflibercept Chemical Structure

Cas No.: 862111-32-8

Tamaño Precio Disponibilidad Cantidad
500ug
437,00 $
Disponible
1mg
702,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Chemical Properties Product Documents

Reseñas

Review for Aflibercept

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Aflibercept

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.